{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:25:29Z","timestamp":1791102329350,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.bcmd.2005.12.024","type":"journal-article","created":{"date-parts":[[2006,2,10]],"date-time":"2006-02-10T01:44:19Z","timestamp":1139535859000},"page":"223-227","source":"Crossref","is-referenced-by-count":47,"title":["The platelet P2 receptors in arterial thrombosis"],"prefix":"10.1016","volume":"36","author":[{"given":"Christian","family":"Gachet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"L\u00e9on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Hechler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2005.12.024_bib1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/192531a0","article-title":"Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets","volume":"192","author":"Gaarder","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2005.12.024_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/194927b0","article-title":"Aggregation of blood platelets by adenosine diphosphate and its reversal","volume":"194","author":"Born","year":"1962","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2005.12.024_bib3","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/01.CIR.72.4.741","article-title":"Adenosine diphosphate as a mediator of platelet aggregation in vivo: an editorial view","volume":"72","author":"Born","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.bcmd.2005.12.024_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-0038-1642759","article-title":"ADP plays a key role in thrombogenesis in rats","volume":"59","author":"Maffrand","year":"1988","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2005.12.024_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0031-6997(24)01373-5","article-title":"Receptors for purines and pyrimidines","volume":"50","author":"Ralevic","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcmd.2005.12.024_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1042\/bj2330309","article-title":"Extracellular ATP: effects, sources and fate","volume":"233","author":"Gordon","year":"1986","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcmd.2005.12.024_bib7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-0037-1616220","article-title":"ADP receptors of platelets and their inhibition","volume":"86","author":"Gachet","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2005.12.024_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0014-5793(97)00022-7","article-title":"The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells","volume":"403","author":"L\u00e9on","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcmd.2005.12.024_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-2999(01)00733-6","article-title":"Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist","volume":"412","author":"Baurand","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcmd.2005.12.024_bib10","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1538-7836.2004.00722.x","article-title":"The P2Y receptor plays an essential role in the platelet shape change induced by collagen when TxA2 formation is prevented","volume":"2","author":"Mangin","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2005.12.024_bib11","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1172\/JCI8399","article-title":"Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice","volume":"104","author":"L\u00e9on","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2005.12.024_bib12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/35051599","article-title":"Identification of the platelet ADP receptor targeted by antithrombotic drugs","volume":"409","author":"Hollopeter","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2005.12.024_bib13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-2005-869523","article-title":"Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis","volume":"31","author":"Savi","year":"2005","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.bcmd.2005.12.024_bib14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1055\/s-2005-869522","article-title":"The P2 receptors and congenital platelet function defects","volume":"31","author":"Cattaneo","year":"2005","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.bcmd.2005.12.024_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.pharmtox.46.120604.141207","article-title":"Regulation of platelet functions by P2 receptors and their inhibition","volume":"46","author":"Gachet","year":"2006","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcmd.2005.12.024_bib16","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1111\/j.1538-7836.2004.00926.x","article-title":"Adenine triphosphate nucleotides are antagonists at the P2Y12 receptor","volume":"2","author":"Kauffenstein","year":"2004","journal-title":"J Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2005.12.024_bib17","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1124\/mol.64.5.1210","article-title":"Purification and functional reconstitution of the human P2Y12 receptor","volume":"64","author":"Bodor","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcmd.2005.12.024_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00062752-200309000-00002","article-title":"Scientific and therapeutic insights into the role of the platelet P2Y12 receptor in thrombosis","volume":"10","author":"Conley","year":"2003","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.bcmd.2005.12.024_bib19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1055\/s-2005-869520","article-title":"The P2 receptors in platelet function","volume":"31","author":"Hechler","year":"2005","journal-title":"Semin. Thromb. Hemostasis"},{"key":"10.1016\/j.bcmd.2005.12.024_bib20","doi-asserted-by":"crossref","first-page":"E101","DOI":"10.1161\/01.ATV.20.11.e101","article-title":"Platelets from a patient heterozygous for the defect of P2CYC receptors for ADP have a secretion defect despite normal thromboxane A2 production and normal granule stores: further evidence that some cases of platelet \u2018primary secretion defect\u2019 are heterozygous for a defect of P2CYC receptors","volume":"20","author":"Cattaneo","year":"2000","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"key":"10.1016\/j.bcmd.2005.12.024_bib21","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1046\/j.1365-2141.1998.01056.x","article-title":"The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel","volume":"103","author":"Hechler","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2005.12.024_bib22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0014-5793(98)00025-8","article-title":"Role of P2Y1 purinoceptor in ADP-induced platelet activation","volume":"422","author":"Savi","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcmd.2005.12.024_bib23","doi-asserted-by":"crossref","first-page":"8070","DOI":"10.1073\/pnas.95.14.8070","article-title":"Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation","volume":"95","author":"Jin","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2005.12.024_bib24","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1161\/01.ATV.0000092127.16125.E6","article-title":"Differential involvement of the P2Y1 and P2Y12 receptors in platelet procoagulant activity","volume":"23","author":"L\u00e9on","year":"2003","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"key":"10.1016\/j.bcmd.2005.12.024_bib25","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1182\/blood-2003-05-1385","article-title":"Platelet ADP receptors contribute to the initiation of intravascular coagulation","volume":"103","author":"L\u00e9on","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2005.12.024_bib26","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1046\/j.1365-2141.2000.02208.x","article-title":"The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity","volume":"110","author":"Storey","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2005.12.024_bib27","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/01.CIR.103.5.718","article-title":"Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist","volume":"103","author":"L\u00e9on","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.bcmd.2005.12.024_bib28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/09537100410001682788","article-title":"Emerging roles for P2X1 receptors in platelet activation","volume":"15","author":"Mahaut-Smith","year":"2004","journal-title":"Platelets"},{"key":"10.1016\/j.bcmd.2005.12.024_bib29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1055\/s-0037-1615684","article-title":"Platelet shape change evoked by selective activation of P2X1 purinoceptors with alpha,beta-methylene ATP","volume":"85","author":"Rolf","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2005.12.024_bib30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1084\/jem.20030144","article-title":"A role of the fast ATP-gated P2X1 cation channel in thrombosis of small arteries in vivo","volume":"198","author":"Hechler","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcmd.2005.12.024_bib31","first-page":"13","article-title":"New insights into the role of P2X1 in platelet function","volume":"87","author":"Cattaneo","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2005.12.024_bib32","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1055\/s-0037-1616060","article-title":"The ATP-gated P2X1 ion channel acts as a positive regulator of platelet responses to collagen","volume":"86","author":"Oury","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2005.12.024_bib33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/sj.bjp.0704486","article-title":"A study of P2X(1) receptor function in murine megakaryocytes and human platelets reveals synergy with P2Y receptors","volume":"135","author":"Vial","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcmd.2005.12.024_bib34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1054\/ceca.2000.0139","article-title":"The roles of P(2X1)and P(2T AC)receptors in ADP-evoked calcium signalling in human platelets","volume":"28","author":"Sage","year":"2000","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bcmd.2005.12.024_bib35","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1055\/s-0037-1614133","article-title":"Identification and biological activity of the active metabolite of clopidogrel","volume":"84","author":"Savi","year":"2000","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2005.12.024_bib36","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2141.1995.tb05319.x","article-title":"Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors","volume":"91","author":"Gachet","year":"1995","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2005.12.024_bib37","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1182\/blood-2002-10-3027","article-title":"Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270","volume":"101","author":"Ding","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2005.12.024_bib38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0049-3848(94)90186-4","article-title":"Evidence for the existence of two different ADP-binding sites on rat platelets","volume":"76","author":"Savi","year":"1994","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bcmd.2005.12.024_bib39","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/01.ATV.12.4.430","article-title":"Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase","volume":"12","author":"Mills","year":"1992","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.bcmd.2005.12.024_bib40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/s-2005-869524","article-title":"Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity","volume":"31","author":"Niitsu","year":"2005","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.bcmd.2005.12.024_bib41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2005-869525","article-title":"Preclinical and clinical studies with selective reversible direct P2Y12 antagonists","volume":"31","author":"van Giezen","year":"2005","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.bcmd.2005.12.024_bib42","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1161\/01.ATV.0000145980.39477.a9","article-title":"Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance","volume":"24","author":"Cattaneo","year":"2004","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"key":"10.1016\/j.bcmd.2005.12.024_bib43","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jacc.2005.01.034","article-title":"Resistance to clopidogrel: a review of the evidence","volume":"45","author":"Nguyen","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcmd.2005.12.024_bib44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1538-7836.2004.01063.x","article-title":"Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases","volume":"3","author":"Aleil","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2005.12.024_bib45","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity","volume":"107","author":"Gurbel","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bcmd.2005.12.024_bib46","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1055\/s-0037-1613462","article-title":"Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement","volume":"89","author":"Muller","year":"2003","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2005.12.024_bib47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ccd.10497","article-title":"Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation","volume":"59","author":"Barragan","year":"2003","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.bcmd.2005.12.024_bib48","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1161\/01.CIR.0000130846.46168.03","article-title":"Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction","volume":"109","author":"Matetzky","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bcmd.2005.12.024_bib49","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1021\/jm981072s","article-title":"Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy","volume":"42","author":"Ingall","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcmd.2005.12.024_bib50","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1055\/s-0037-1615596","article-title":"Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes","volume":"85","author":"Storey","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2005.12.024_bib51","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/0953710021000024402","article-title":"Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease","volume":"13","author":"Storey","year":"2002","journal-title":"Platelets"},{"key":"10.1016\/j.bcmd.2005.12.024_bib52","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0149-2918(02)85149-9","article-title":"Safety profile and tolerability of intravenous AR-C69931MX, a new antiplatelet drug, in unstable angina pectoris and non-Q-wave myocardial infarction","volume":"24","author":"Jacobsson","year":"2002","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bcmd.2005.12.024_bib53","first-page":"13","article-title":"Development of reversible P2Y12 receptor antagonists","volume":"89","author":"Boyer","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2005.12.024_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjp.0701837","article-title":"Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2\u2032-deoxyadenosine 3\u2032,5\u2032-bisphosphate","volume":"124","author":"Boyer","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcmd.2005.12.024_bib55","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.bcp.2004.06.026","article-title":"Antiaggregatory activity in human platelets of potent antagonists of the P2Y 1 receptor","volume":"68","author":"Cattaneo","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcmd.2005.12.024_bib56","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.105.094037","article-title":"MRS2500, a potent, selective and stable antagonist of the P2Y1 receptor, with strong antithrombotic activity in mice","author":"Hechler","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcmd.2005.12.024_bib57","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/13522","article-title":"Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice","volume":"5","author":"Fabre","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcmd.2005.12.024_bib58","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1046\/j.1538-7836.2003.00144.x","article-title":"Inhibition of localized thrombosis in P2Y1-deficient mice and rodents treated with MRS2179, a P2Y1 receptor antagonist","volume":"1","author":"Lenain","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2005.12.024_bib59","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1161\/01.ATV.0000163184.02484.69","article-title":"Importance of platelet phospholipase Cgamma2 signaling in arterial thrombosis as a function of lesion severity","volume":"25","author":"Nonne","year":"2005","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"key":"10.1016\/j.bcmd.2005.12.024_bib60","article-title":"The role of the P2Y1, P2Y12, and P2X1 platelet receptors in a laser induced model of arterial thrombosis in vivo","author":"Lenain","year":"2003"},{"key":"10.1016\/j.bcmd.2005.12.024_bib61","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/01.ATV.0000057809.32354.22","article-title":"In vivo blockade of platelet ADP receptor P2Y12 reduces embolus and thrombus formation but not thrombus stability","volume":"23","author":"van Gestel","year":"2003","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"key":"10.1016\/j.bcmd.2005.12.024_bib62","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ejmech.2004.01.007","article-title":"Structure\u2013activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X1 receptor antagonist","volume":"39","author":"Kassack","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcmd.2005.12.024_bib63","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1124\/jpet.105.084673","article-title":"Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449","volume":"314","author":"Hechler","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."}],"updated-by":[{"DOI":"10.1016\/j.bcmd.2012.05.013","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T00:00:00Z","timestamp":1344988800000}}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979606000313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979606000313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T18:12:57Z","timestamp":1736273577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979606000313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S1079979606000313"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2005.12.024","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}